Author:
Mader Robert M.,Steger G�nther G.,Moser Kurt,Rainer Hugo,Krenmaryr Peter,Dittrich Christian
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference21 articles.
1. Allen LM, Tejada F, Okonmah AD, Nordqvist S (1982) Combination chemotherapy of the epipodophyllotoxin derivatives teniposide and etoposide. A pharmacodynamic rationale? Cancer Chemother Pharmacol 7: 151?156
2. Beijnen JH, Holthuis JJ, Kerkdijk HG, Houwen OA van der, Paalman AC, Bult A, Underberg WJ (1988) Degradation kinetics of etoposide in aqueous solution. Int J Pharmacol 41: 169?178
3. D'Incalci M, Farina P, Sessa C, Mangioni C, Conter V, Masera G, Rocchetti M, Pisoni MB, Piazza E, Beer M, Cavalli F (1982) Pharmacokinetics of VP 16-213 given by different administration methods. Cancer Chemother Pharmacol 7: 141?145
4. Evans WE, Sinkule JA, Horvath A, Crom WR, Dow LW, Rivera G (1981) Clinical pharmacology of VM 26 and VP 16 in children with cancer. Proc Am Assoc Cancer Res Am Soc Clin Oncol 22: 174
5. Evans WE, Sinkule JA, Crom WR, Dow L, Look AT, Rivera G (1982) Pharmacokinetics of teniposide (VM 26) and etoposide (VP 16) in children with cancer. Cancer Chemother Pharmacol 7: 147?150
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献